Edelman MJ, Dvorkin M, Laktionov K, Navarro A, et al. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer 2022;166:135-142.
PMID: 35278766